Jakarta. Pelita Harapan Education Foundation, or YPPH, hosted a Covid-19 vaccination clinic for Sekolah Pelita Harapan, or SPH, students aged 12-17 years old on Sunday.
SPH's vaccination clinic took place at its main campus in Tangerang, Lippo Village.
SPH is the first school in the Greater Jakarta area as well as the first private school in Indonesia to hold the Covid-19 vaccination for adolescents. All SPH students across the five campuses — namely SPH Lippo Village, Sentul City, Lippo Cikarang, Kemang Village, and Pluit Village — can get their Covid-19 shots. On July 2-4, SPH also offered vaccination for students’ parents.
Both the student's and parents' vaccination uses Sinovac's Covid-19 vaccine.
“The health and safety of our school community remain a top priority for the Pelita Harapan Education Foundation. Vaccination is a key component of school reopening in the coming months. When students are vaccinated, we can protect families as well as our teachers and staff,” YPPH executive director Stephanie Riady said in a statement on Sunday.
“For this first stage, we are providing 600 vaccine doses for Sekolah Pelita Harapan and Dian Harapan students,” she said.
According to SPH, vaccination is a crucial step to ensure safe in-person learning in the upcoming 2021/2022 academic year, which will kick off in early August.
“We are grateful that the Indonesian government is working efficiently to accelerate the vaccinations for everyone. This program is vital in safeguarding our community and essential in our school reopening plans in August,” administration director Emilia Djohan said.
“We expect most of our community to be vaccinated so that learning can once again resume without any disruption.”
A recent circular issued by the Ministry of Health urged for children’s vaccination to be prioritized immediately. Children’s vaccination has been declared safe with the recommendation from the Indonesian Technical Advisory Group on Immunization (Itagi).
The Food and Drug Supervisory Agency (BPOM) has also given its nod for using the Sinovac Covid-19 vaccine for adolescents aged 12-17 years old.